Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
starScience is a German life sciences company based in Heidelberg that specializes in metabolic health, focusing on obesity, prediabetes, and diabetes. Founded in 2015 by Prof. Per Humpert, the company serves as an accelerator for novel scientific approaches, particularly in the food as medicine space and the development of diagnostic tools. starScience collaborates closely with clinical partners like Stoffwechselzentrum Rhein-Pfalz to evaluate evidence-based concepts and conduct clinical studies. Their work includes the scientific validation of nutritional supplements, such as amino acid and chromium-based functional drinks designed to regulate postprandial glucose levels. The company provides a range of services from study protocol development to laboratory analysis and medical writing, aiming to bridge the gap between scientific ideas and peer-reviewed publications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StarScience.